ISODIOL INTERNATIONAL (OTCMKTS:ISOLF) an international Bioactive Phytoceutical innovator focusing on the development of nutraceutical and pharmaceutical products, reported that its division named C3 Global Biosciences has agreed in principle to buy the rights to become the sole worldwide supplier of Advanced Brain Monitoring’s Electroencephalogram technology in the phytoceutical segment, especially the cannabis community.
The details
For the previous 15 years, Advanced Brain Monitoring has challenged traditional thinking by advancing unique medical devices that offer lower healthcare costs, improved quality of care and superior patient experience. With this versatile, advanced wireless EEG system, understanding of physiological indications across different variety of real-world applications are eventually here. The EEG system will enable researchers’ and physicians’ real-time feedback on the impact of Cannabis offerings. This EEG device marks as reimbursable and has selected CPT codes for physicians to file to health insurance firms.
Andrew Serafini, the President of C3GBS, expressed that the requirement to fast-track and get to market therapeutic unique compounds that possess remarkable potential in human ailments have a requirement for an FDA-permitted drug validation know-how that should turn mandatory. The cannabis industry doesn’t have verification methodologies and C3GBS is thrilled to bring the EEG know-how to the forefront to assist further identify the advantages in real time. This will invariably lead in evidence-based report gathering to help guide and support the healthcare practitioner.
Marcos Agramont, the CEO of Isodiol, reported that this marks as another monumental initiative taken by company and C3GBS to be the international pioneer in cannabis research, innovation, technology and science to positively impact patient results. The EEG system provides another diagnostic device that is FDA permitted, to help comprehend how cannabis is advantageous to the human body.
Isodiol International is the market leader in nutraceutical and pharmaceutical grade phytochemical compounds and the pioneer in the development and manufacturing of Phytoceutical consumer products.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure
Read Again http://mmjreporter.com/isodiol-international-otcmktsisolf-buys-international-rights-to-manufacture-products-under-a-unique-delivery-system-patent-33238.htmlBagikan Berita Ini
0 Response to "ISODIOL INTERNATIONAL (OTCMKTS:ISOLF) Buys International Rights To Manufacture Products Under A Unique ..."
Post a Comment